Bashir Jaffer, President & CEO

Chemokine's goal is to identify and develop multiple drug candidates for the treatment of cancer, blood disorders, cardiovascular and infectious disease. To that end, Chemokine Therapeutics has invested a significant amount of resources in protecting our discoveries with strong patents with terms providing at least 20-years of protection. In addition, to further safeguard our position, we maintain a collaboration and publication strategy to ensure our scientific findings are published in peer reviewed journals and with leading experts in academic community.